Immune Pharmaceuticals (IMNPQ) News Today $0.0010 0.00 (0.00%) As of 08/17/2022 Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Piper Sandler Sticks to Its Buy Rating for Immunome (IMNM)November 14, 2024 | markets.businessinsider.comDistinct immune profiles linked to adverse reactions from immunotherapyOctober 16, 2024 | msn.comFact Check: Fact Check: German study did not find mRNA shots ‘eat away’ at children’s immune systemsSeptember 11, 2024 | reuters.comThese Stocks Are Moving the Most Today: Alpine Immune, Vertex, Robinhood, Regeneron, Costco, Constellation Brands, CarMax, and MoreApril 11, 2024 | msn.comVertex Pharmaceuticals to Buy Alpine Immune Sciences for $4.9 BillionApril 10, 2024 | money.usnews.comAlpine Immune Sciences Shares Rally After Vertex Agrees to Acquire Co.April 10, 2024 | marketwatch.comVertex Pharma bets on kidney disease treatment with $4.9 billion Alpine Immune dealApril 10, 2024 | msn.comJ&J's immune disorder drug succeeds in studiesFebruary 5, 2024 | reuters.comAC Immune: Initial AD Findings Bring About Two Upcoming CatalystsDecember 20, 2023 | seekingalpha.comBest Vitamins And Foods To Boost Your Immune SystemDecember 20, 2023 | forbes.comAC Immune Raises $50M, Its Alzheimer's Targeting Immunotherapy Advances Into Phase 2b TrialDecember 15, 2023 | markets.businessinsider.comRegeneron’s Veopoz scores FDA approval for rare immune diseaseAugust 21, 2023 | msn.comFDA Approves Regeneron's Drug For Ultra Rare Immune DisorderAugust 21, 2023 | msn.comRegeneron wins approval for rare immune disease therapy pozelimabAugust 18, 2023 | seekingalpha.comNatural Immune Booster Market to Reach $19.67 Billion by 2030, Says Coherent Market Insights (CMI)July 28, 2023 | benzinga.comImmune Check Point Inhibitor Market Size, Latest Trends, Key Players, Revenue, Report, And Forecast 2031April 22, 2023 | marketwatch.comHuman Immune Health Supplements Market Size and New Revenue Techniques By 2031March 28, 2023 | marketwatch.comNatural Immune Booster Market Top Players By 2031March 24, 2023 | marketwatch.comJudge: Oxford Schools, Staff Immune From Shooting LawsuitsMarch 6, 2023 | usnews.comImmune Therapeutics, Inc. Announces Shareholder Approval of Name Change to Biostax Corp. and Unveils New Website, Business Strategies and DirectionMarch 1, 2023 | benzinga.comGlobal Natural Immune Booster Market Report Historical, Current, and Projected Size, in terms of value 2030 By VMReportsFebruary 28, 2023 | marketwatch.comChelsea Handler declares she's immune to cancel culture because she's not ‘racist,’ ‘sexist’ ‘idiot’January 14, 2023 | foxnews.comStudy shows convalescent plasma works for immune-compromised Covid-19 patients, but it can be hard to findJanuary 14, 2023 | cnn.comImmune system-evading hybrid virus observed for first timeOctober 27, 2022 | theguardian.comFor those with HIV or weak immune systems, monkeypox can be fatal -U.S. studyOctober 26, 2022 | reuters.comTargeting One Type of Immune Cell With Another Slows Cancer Growth in Preclinical StudiesOctober 25, 2022 | yahoo.comPositive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published in NEJMSeptember 12, 2022 | markets.businessinsider.comCour Pharmaceuticals secures funding to transform the way allergies and autoimmune disorders are treatedSeptember 7, 2022 | bizjournals.comLogicBio Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateAugust 15, 2022 | markets.businessinsider.comIMNPQ.PK - | Stock Price & Latest News | ReutersAugust 14, 2022 | reuters.comImmune Pharmaceuticals (OTC:IMNPQ), Analyst Ratings, Price Targets, PredictionsAugust 9, 2022 | benzinga.comImmune Pharmaceuticals, Inc. (IMNPQ)July 16, 2022 | finance.yahoo.comVBL Therapeutics Receives FDA Fast Track Designation for Ofra-Vec for the Treatment of Platinum-Resistant Ovarian CancerApril 26, 2022 | apnews.comImmune Pharmaceuticals Inc.August 28, 2021 | barrons.com Get Immune Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNPQ and its competitors with MarketBeat's FREE daily newsletter. Email Address IMNPQ Media Mentions By Week IMNPQ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMNPQ News Sentiment▼0.000.44▲Average Medical News Sentiment IMNPQ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMNPQ Articles This Week▼00▲IMNPQ Articles Average Week Get Immune Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNPQ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FFNTF News AGNPF News ALST News HIPH News LEAS News ARNI News AZNCF News AVXT News AVVH News AXIM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:IMNPQ) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immune Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immune Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
